CH478116A - Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate - Google Patents

Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate

Info

Publication number
CH478116A
CH478116A CH1608567A CH1608567A CH478116A CH 478116 A CH478116 A CH 478116A CH 1608567 A CH1608567 A CH 1608567A CH 1608567 A CH1608567 A CH 1608567A CH 478116 A CH478116 A CH 478116A
Authority
CH
Switzerland
Prior art keywords
dihydro
hydroxy
dimethyl
preparation
new
Prior art date
Application number
CH1608567A
Other languages
English (en)
Inventor
Ernst Dr Jucker
Anton Dr Ebnoether
Andre Dr Stoll
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority to CH1608567A priority Critical patent/CH478116A/de
Priority claimed from CH891264A external-priority patent/CH455776A/de
Priority to NL6508457A priority patent/NL6508457A/xx
Publication of CH478116A publication Critical patent/CH478116A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
CH1608567A 1964-07-07 1964-07-07 Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate CH478116A (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CH1608567A CH478116A (de) 1964-07-07 1964-07-07 Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate
NL6508457A NL6508457A (de) 1964-07-07 1965-07-01

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1608567A CH478116A (de) 1964-07-07 1964-07-07 Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate
CH891264A CH455776A (de) 1964-07-07 1964-07-07 Verfahren zur Herstellung neuer 9,10-Dihydro-10,10-dimenthyl-anthracen-derivate

Publications (1)

Publication Number Publication Date
CH478116A true CH478116A (de) 1969-09-15

Family

ID=25703964

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1608567A CH478116A (de) 1964-07-07 1964-07-07 Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate

Country Status (2)

Country Link
CH (1) CH478116A (de)
NL (1) NL6508457A (de)

Also Published As

Publication number Publication date
NL6508457A (de) 1966-01-10

Similar Documents

Publication Publication Date Title
CH477462A (de) Verfahren zur Herstellung neuer Diazacycloalkane
CH451172A (de) Verfahren zur Herstellung neuer substituierter Phenylamino-1,3-diazacyclopentene-(2)
AT257570B (de) Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol
CH467798A (de) Verfahren zur Herstellung neuer 1,3-Dioxan-Derivate
AT262984B (de) Verfahren zur Herstellung neuer basisch substituierter Naphthalin-(1,4,5,8)-tetracarbonsäurediimide
CH471117A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
CH471136A (de) Verfahren zur Herstellung neuer 1,3-Dihydro-5-aryl-2H-1,4-benzodiazepin-2-on-4-oxyde
CH472390A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
AT280493B (de) Verfahren zur Herstellung neuer Gona-4,9,11-triene
CH471828A (de) Verfahren zur Herstellung neuer 1,2a-Methylen-5a-androstanderivate
CH505807A (de) Verfahren zur Herstellung neuer 8,14-seco-B-Homogonane
CH487901A (de) Verfahren zur Herstellung neuer 2-Methyl-3-phenyl-3H-4-chinazolone
CH467257A (de) Verfahren zur Herstellung neuer Isatin-B-Thiosemicarbazone
AT295515B (de) Verfahren zur Herstellung neuer 3,5-Dioxo-pyrazolidine
CH478116A (de) Verfahren zur Herstellung neuer 9,10-Dihydro-9-hydroxy-10,10-dimethyl-anthracen-derivate
CH455776A (de) Verfahren zur Herstellung neuer 9,10-Dihydro-10,10-dimenthyl-anthracen-derivate
AT273074B (de) Verfahren zur Herstellung neuer 1,1-Dihydroxyphenylpropyl-3-thioäther
AT253146B (de) Verfahren zur Herstellung neuer 17-Hydroxyöstra-1, 3, 5 (10)-trien-[16c-17]-dihydropyrazole
CH459193A (de) Verfahren zur Herstellung neuer 1-Methyl- 1-5a-androsten-17B-ol-3-on-17-ester
AT250967B (de) Verfahren zur Herstellung neuer Derivate des 1, 2-Malonyl-1, 2-dihydrocinnolins
CH457441A (de) Verfahren zur Herstellung von 3,8-Diazabicyclooctanderivaten von Phenothiazinen
CH481890A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
CH481129A (de) Verfahren zur Herstellung neuer 3,1-Benzothiazin-Derivate
AT268560B (de) Verfahren zur Herstellung neuer 3-Oxo-2-oxa-4,9,11-gonatriene
CH449023A (de) Verfahren zur Herstellung 5-basisch substituierter 5,6-Dihydro-6-oxomorphanthridine

Legal Events

Date Code Title Description
PL Patent ceased